- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Vestcor Inc Reduces Stake in Eli Lilly and Company
Institutional investor decreases holdings in pharmaceutical giant by 11.6% in Q3
Published on Mar. 9, 2026
Got story updates? Submit your updates here. ›
Vestcor Inc, an investment management firm, decreased its stake in shares of Eli Lilly and Company (NYSE:LLY) by 11.6% during the third quarter, according to a recent SEC filing. The fund now owns 28,728 shares of the company's stock, valued at $21.9 million, making it the 29th largest holding in Vestcor's investment portfolio.
Why it matters
Eli Lilly is one of the world's largest pharmaceutical companies, known for developing innovative medicines across a range of therapeutic areas. Institutional investors closely monitor changes in ownership of Lilly's stock, as it can signal broader market sentiment and investment trends within the healthcare sector.
The details
According to the 13F filing, Vestcor sold 3,775 shares of Eli Lilly during the third quarter, reducing its total position to 28,728 shares. The move comes as Lilly's stock price has risen significantly over the past year, reaching new all-time highs. Vestcor's holdings in Lilly now account for approximately 0.7% of its total investment portfolio.
- Vestcor decreased its Eli Lilly stake during the third quarter of 2026.
The players
Vestcor Inc
An investment management firm that owns a portfolio of stocks, including shares in pharmaceutical giant Eli Lilly and Company.
Eli Lilly and Company
A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide.
The takeaway
The reduction in Vestcor's Eli Lilly holdings, while relatively small, could signal a broader shift in investor sentiment around the stock as it has reached new highs. However, Lilly remains a core holding for the firm, underscoring the company's continued importance in the pharmaceutical landscape.
Indianapolis top stories
Indianapolis events
Mar. 11, 2026
Lords Of The Sound Orchestra "The Music Of Hans Zimmer"Mar. 11, 2026
Colter Wall - Memories and EmptiesMar. 12, 2026
Indiana Pacers vs. Phoenix Suns




